if it is confirmed that monobactams such as aztreonam are minimally cross-reactive , well-tolerated by subjects allergic to other beta-lactam antibiotics , and only weakly immunogenic , fewer allergic reactions may be associated with antimicrobial therapy in the future than have been seen with the other available beta-lactam antibiotic drugs .
C0004521
aztreonam
C0020517
allergic reactions